Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

被引:30
|
作者
Muhs B.E. [1 ]
Gagne P. [1 ]
Sheehan P. [1 ]
机构
[1] Diabetes Foot and Ankle Center, Hospital for Joint Diseases, New York, NY 10003
关键词
Peripheral Arterial Disease; Peripheral Arterial Occlusive Disease; Limb Salvage Rate; Secondary Patency Rate; Crural Artery;
D O I
10.1007/s11892-005-0063-7
中图分类号
学科分类号
摘要
Peripheral arterial disease (PAD) is an under-recognized complication of diabetes. Recently, prevalence estimates in patients with diabetes over 50 years of age have been placed at 25% to 30%. The main reason for under-reporting is the largely asymptomatic nature of PAD in diabetes. Nonetheless, it is important to diagnose PAD because it is a marker of systemic atherosclerosis with excess cardiovascular risk, and it may identify of limb loss. The most sensitive and specific diagnostic tool is an ankle-brachial index. Imaging studies are performed in patients who are candidates for revascularization. The most durable and effective revascularization procedure for PAD in diabetes is surgical bypass with saphenous vein as the conduit. Endovascular interventions are best used in patients with proximal disease with short-segment stenoses. The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. Presently, clinicians would include "selected" patients with intermittent claudication who have disabling symptoms and proximal disease above the inguinal ligament. Copyright © 2005 by Current Science Inc.
引用
收藏
页码:24 / 29
页数:5
相关论文
共 50 条
  • [21] Ayurveda for a type 1 diabetes patient with peripheral arterial occlusive disease (PAOD)
    Stapelfeldt, Elmar
    Berger, Bettina
    Raak, Christa K.
    Gupta, Shivenarain
    COMPLEMENTARY MEDICINE RESEARCH, 2024, 31 (01) : 94 - 102
  • [22] PERIPHERAL ARTERIAL DISEASE STATUS AND CARDIOVASCULAR OUTCOMES IN THE BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES TRIAL
    Abbott, J. Dawn
    Lombardero, Manuel
    Barsness, Greg
    Pena-Sing, Ivan
    Buitron, Luisa
    Singh, Prem
    Woodhead, Gail
    Tardif, Jean-Claude
    Kelsey, Sherry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [23] Approach to the Patient With Peripheral Arterial Disease
    Wennberg, Paul W.
    CIRCULATION, 2013, 128 (20) : 2241 - 2250
  • [24] Dual Antiplatelet Therapy in Peripheral Arterial Disease and After Peripheral Percutaneous Revascularization
    Hanna, Elias B.
    JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (12): : 679 - 684
  • [25] CLINICAL-ASSESSMENT OF CHRONIC OCCLUSIVE PERIPHERAL ARTERIAL-DISEASE
    SCHATZ, IJ
    HAWAII MEDICAL JOURNAL, 1977, 36 (05): : 138 - 142
  • [26] Predictors of mortality after peripheral enclovascular - Revascularization for symptomatic peripheral arterial disease
    Safley, David M.
    House, John A.
    Daniel, William C.
    Laster, Steven B.
    Marso, Steven P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 204L - 204L
  • [27] Cardiac rehabilitation in patients with peripheral arterial disease after revascularization
    Sami, Farhad
    Ranka, Sagar
    Lippmann, Mathew
    Weiford, Brian
    Hance, Kirk
    Whitman, Bob
    Wright, Lanecia
    Donaldson, Seth
    Boyer, Blake
    Gupta, Kamal
    VASCULAR, 2021, 29 (03) : 350 - 354
  • [28] COURSE OF PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE IN DIABETES - VASCULAR LABORATORY ASSESSMENT
    OSMUNDSON, PJ
    OFALLON, WM
    ZIMMERMAN, BR
    KAZMIER, FJ
    LANGWORTHY, AL
    PALUMBO, PJ
    DIABETES CARE, 1990, 13 (02) : 143 - 152
  • [29] Safety and Efficacy of Hybrid Revascularization Procedures for Peripheral Arterial Disease
    Rehring, Thomas F.
    Tsai, Thomas T.
    Jazaeri, Omid
    Go, Alan S.
    Gupta, Rajan
    Hedayati, Nasim
    Ho, P. M.
    Jones, William S.
    Patel, Manesh R.
    Rogers, Robert K.
    Magid, David J.
    JOURNAL OF VASCULAR SURGERY, 2015, 61 (06) : 160S - 161S
  • [30] FUNCTIONAL BENEFIT OF REVASCULARIZATION FOR PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE
    REGENSTEINER, JG
    HARGARTEN, ME
    RUTHERFORD, RB
    HIATT, WR
    CLINICAL RESEARCH, 1991, 39 (02): : A404 - A404